Other languages Demant A/S

Equities

Market Closed - Nasdaq Copenhagen Other stock markets 10:59:49 2024-05-31 am EDT			5-day change	1st Jan Change
329 ^DKK	+0.92%		+0.12%	+11.15%

May. 29	UK’s Competition Regulator Closes Cochlear-Demant Deal	MT
May. 21	Denmark's Demant Completes Sale of Cochlear Implants Business	MT

UK’s Competition Regulator Closes Cochlear-Demant Deal	May. 29
Denmark's Demant Completes Sale of Cochlear Implants Business	May. 21
Demant A/S: Closing of divestment of cochlear implants business	May. 21
Cochlear Limited acquired Oticon Medical A/s from Demant A/S.	May. 20
DEMANT : Q1 sales miss; organic growth guidance unchanged	May. 06
Transcript : Demant A/S, Q1 2024 Interim Management Statement Call, May 06, 2024	May. 06
Hearing Healthcare Company Demant Affirms FY24 Outlook	May. 06
Demant A/S: Interim Management Statement for Q1 2024	May. 06
Demant A/S Provides Earnings Guidance for the Year 2024	May. 06
Denmark's Demant Finalizes Capital Reduction	Apr. 08
Demant A/S: Completion of capital reduction in Demant A/S	Apr. 08
Competition Regulator Clears Cochlear’s Acquisition of Oticon Medical’s Cochlear Implant Business	Apr. 03
Demant Seeks Acquisitions	Mar. 12
Transcript : Demant A/S - Analyst/Investor Day	Mar. 12
Demant A/S: Capital Markets Day 2024 - Sharpened focus on Hearing Healthcare	Mar. 12
Demant A/S: Decisions of Annual General Meeting	Mar. 06
Nordic Stocks Closed Down Wednesday; Electrolux Series a Posted Biggest Loss	Feb. 28
Demant A/S: Transactions with Demant shares by Board of Directors and Executive Board and closely related parties	Feb. 28
Demant A/S: Notice of annual general meeting	Feb. 07
Anja Madsen Announces Not to Stand for Re-Election to the Board of Directors of Demant A/S	Feb. 07

No results for this search

DEMANT : Q1 sales miss; organic growth guidance unchanged

May 06, 2024 at 11:18 am EDT